In gliomas, Huillard et al. report significantly increased survival in mice transplanted with human V600E mutated astrocytoma cells when treated with the first generation BRAF inhibitor vemurafenib (PLX4720) (41). The gene discussed is BRAF; the disease is astrocytoma (excluding glioblastoma).